Promise of new Japanese encephalitis vaccines

被引：13

作者：

Fischer, Marc ^{[1
]}

Casey, Christine

Chen, Robert T.

机构：

[1] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vector Borne & Enter Dis, Ft Collins, CO 80521 USA

[2] Ctr Dis Control & Prevent, Off Chief Sci Officer, Atlanta, GA USA

[3] Ctr Dis Control & Prevent, Natl Ctr HIV Hepatitis STD & TB, Atlanta, GA USA

来源：

LANCET | 2007年 / 370卷 / 9602期

关键词：

D O I：

10.1016/S0140-6736(07)61753-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1806 / 1808

页数：3

共 14 条

[11] Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States [J].

Takahashi, H ;

Pool, V ;

Tsai, TF ;

Chen, RT .

VACCINE, 2000, 18 (26) :2963-2969

[12] Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case-control study in Nepalese children 5 years after immunization [J].

Tandan, J. B. ;

Ohrr, Heechoul ;

Sohn, Young Mo ;

Yoksan, Sutee ;

Ji, Min ;

Nam, Chung Mo ;

Halstead, Scott B. .

VACCINE, 2007, 25 (27) :5041-5045

[13] Safety and immunogenicity of a Vero-cell-derived,inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial [J].

Tauber, E. ;

Kollaritsch, H. ;

Korinek, M. ;

Rendi-Wagner, P. ;

Jilma, B. ;

Firbas, C. ;

Schranz, S. ;

Jong, E. ;

Klingler, A. ;

Dewasthaly, S. ;

Klade, C. S. .

LANCET, 2007, 370 (9602) :1847-1853

[14]

*WHO, 2005, WKLY EPIDEMIOL REC, V80, P241

← 1 2 →